PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pre-clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD 20850, USA.\', \'Division of Pre-clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD 20850, USA. Electronic address: huangru@mail.nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1359-6446(21)00244-010.1016/j.drudis.2021.05.012
?:doi
?:hasPublicationType
?:journal
  • Drug discovery today
is ?:pmid of
?:pmid
?:pmid
  • 34048893
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.008
?:rankingScore_hIndex
  • 150
?:title
  • High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34048893>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34048893>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all